𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer pharmacogenomics: international trends

✍ Scribed by Yasuko Yamayoshi; Emiko Iida; Yusuke Tanigawara

Book ID
106284778
Publisher
Springer
Year
2005
Tongue
English
Weight
434 KB
Volume
10
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

International trends in prostatic cancer
International trends in prostatic cancer
✍ David G. Zaridze; Peter Boyle; Michel Smans πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 681 KB

The most m e n t data available demonstrate a 120-fold difference between the lowest and highest incidence rates of prostatic cancer, the disease being very common in North America, particularly among Blacks, and in Scandinavia, while it is rare in Japan and other oriental countries. The highest mor

Colorectal cancer pharmacogenomics
Colorectal cancer pharmacogenomics
✍ Sharon Marsh; Jinsheng Yu; Janelle M. Hoskins πŸ“‚ Article πŸ“… 2006 πŸ› Current Science Inc. 🌐 English βš– 139 KB
International trends and patterns of pri
International trends and patterns of primary liver cancer
✍ Katherine A. McGlynn; Lilian Tsao; Ann W. Hsing; Susan S. Devesa; Joseph F. Frau πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 156 KB

Primary liver cancer (PLC) is common in many areas of the developing world, but uncommon in most of the developed world. Some evidence suggests, however, that the global pattern of PLC may be changing. To clarify this issue, we examined incidence rates for PLC over the 15-year time period, 1978 -92,

International patterns and trends in tes
International patterns and trends in testis cancer incidence
✍ Mark P. Purdue; Susan S. Devesa; Alice J. Sigurdson; Katherine A. McGlynn πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 128 KB

## Abstract Although the incidence of testis cancer has risen markedly in many Western populations over the past half‐century, it is not clear whether rates in other populations also have increased. To clarify this issue, we examined testis cancer incidence rates over the 25‐year time period of 197